EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development

Drake D Pedersen iD, Keishi Kohyama iD, Taro Fujii, Marianna Barbuto iD, Sangho Ye iD, Sujeong Park iD, Flaviana Falci, Jooyoun Park, Keun Seok Seo iD, William Long, Antonio D'Amore, Seungil Kim iD und 1 weitere

Journal of Biomedical Materials Research Part A · 2026-11 · 114 (11)

DOI: 10.1002/jbm.a.70172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 21.10.2026. Verfasst von Drake D Pedersen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Polyurethanes, Ascorbic Acid, Antioxidants, Tissue Scaffolds. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prosthetic heart valve development consists of several branching, innovative strategies to mediate the complex native environment that wears down valve durability. Anti‐calcification treatments are being applied to pericardial tissue, durable polymers are being developed that mitigate oxidative degradation and stress cracking, and heart valve tissue engineering has introduced resorbable scaffolds that can develop into stable, functional tissue. In each case, an increasing breadth of strategies is being developed to curb the persistent issue of valve deterioration. This study aimed to synthesize and characterize an ascorbic acid‐containing polyurethane to impart antioxidant properties to degradable scaffolds for tissue engineered heart valve (TEHV) replacement. Blends of poly(carbonate‐ascorbic acid) urethane (PCAU) and poly(carbonate urethane) urea (PCUU) were fabricated into microporous scaffolds to evaluate the impact of PCAU in vitro on mechanics, degradation, cell viability, calcification, bacterial adhesion, and in vivo on native tissue response in a juvenile rat subcutaneous model. PCAU blended with PCUU in a 25:75 ratio (PCAU‐25) had mechanical properties similar to PCUU, while higher concentrations of PCAU were not mechanically robust. PCAU‐25 showed greater reactive oxygen species (ROS) inhibition and degradation, and reduced calcification and bacterial adhesion in vitro. In a juvenile rat subcutaneous model, both PCUU and PCAU‐25 groups showed negligible calcification after 4 weeks. PCAU‐25, however, showed much greater cell infiltration and immune response, possibly due to an accelerated rate of degradation. PCAU‐25 was then fabricated into a polymeric valve scaffold and underwent basic mechanical and hydrodynamic performance assessment that demonstrated function similar to PCUU valves previously reported. These findings demonstrate proof‐of‐concept for a new polyurethane formulation incorporating ascorbic acid for antioxidant bioactivity and translatability into a functional TEHV scaffold.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyurethanesAscorbic AcidAntioxidantsTissue ScaffoldsHeart Valve ProsthesisAnimalsRatsRats, Sprague-DawleyTissue Engineering

Stichwörter der Autor:innen

antioxidantascorbic acidcalcificationpolyurethanetissue engineered heart valve

Substanzen

PolyurethanesAscorbic AcidAntioxidantspoly(carbonate urea) urethane

Autor:innen und Institutionen

  • Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Ri.MED Foundation, Cardiac Tissue Engineering Laboratory, Palermo, Italy.
  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.
  • Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Starkville, Mississippi, USA.
  • Biomedical Engineering, Department of Agricultural and Biological Engineering, Mississippi State University, Starkville, Mississippi, USA.

ORCID-Profile: Drake D Pedersen, Keishi Kohyama, Marianna Barbuto, Sangho Ye, Sujeong Park, Keun Seok Seo, Seungil Kim, William R Wagner

Zitieren

APA

Pedersen, D. D., Kohyama, K., Fujii, T., Barbuto, M., Ye, S., Park, S., Falci, F., Park, J., Seo, K. S., Long, W., D'Amore, A., Kim, S., & Wagner, W. R. (2026). An Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development. Journal of Biomedical Materials Research Part A, 114(11). https://doi.org/10.1002/jbm.a.70172

Vancouver

Pedersen DD, Kohyama K, Fujii T, Barbuto M, Ye S, Park S, et al. An Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development. Journal of Biomedical Materials Research Part A. 2026;114(11). doi:10.1002/jbm.a.70172

BibTeX
@article{Pedersen2026,
  author = {Pedersen, Drake D and Kohyama, Keishi and Fujii, Taro and Barbuto, Marianna and Ye, Sangho and Park, Sujeong and Falci, Flaviana and Park, Jooyoun and Seo, Keun Seok and Long, William and D'Amore, Antonio and Kim, Seungil and Wagner, William R},
  title = {An Ascorbic‐Acid Containing Poly(Carbonate) Urethane With Antioxidant Bioactivity for Application in Heart Valve Scaffold Development},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  volume = {114},
  number = {11},
  doi = {10.1002/jbm.a.70172}
}
Kostenlos starten →